NCT03793543View on ClinicalTrials.gov

Test-Retest Reproducibility of 18F-DCFPyL PET/CT in the Evaluation of Patients With Metastatic Prostate Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

March 27, 2019

Primary Completion Date

March 6, 2020

Study Completion Date

October 15, 2021

Conditions
Prostate Cancer
Interventions
DRUG

18F-DCFPyL Injection

A single dose of 9±1 mCi (333±37 MBq) IV injection of 18F-DCFPyL

Trial Locations (1)

21287

Johns Hopkins University, Baltimore

All Listed Sponsors
lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT03793543 - Test-Retest Reproducibility of 18F-DCFPyL PET/CT in the Evaluation of Patients With Metastatic Prostate Cancer | Biotech Hunter | Biotech Hunter